Cellular DNA synthesis machinery

The cellular DNA synthesis machinery is a highly coordinated multi-protein complex, primarily centered around the replisome, that executes the replication of genomic DNA during the S phase of the cell cycle (StatPearls, Genetics, DNA Replication). Key components include DNA polymerases (alpha, delta, and epsilon), helicases such as the MCM complex, primase, and topoisomerases, which collectively ensure high-fidelity duplication of the genetic code (NIH, DNA Replication). In oncology, this machinery is a critical therapeutic target because malignant cells exhibit accelerated proliferation and a continuous requirement for DNA synthesis (PubMed, PMID: 28653641). Drugs like antimetabolites, including cytarabine and gemcitabine, disrupt these processes by mimicking natural nucleotides or directly blocking enzymatic activity, leading to replication stress and apoptosis (NCBI, Antimetabolites). Beyond cancer, components of the DNA synthesis apparatus are targeted by antiviral agents to prevent the replication of viral genomes within host cells. However, the lack of absolute specificity for cancerous versus healthy rapidly dividing cells leads to common toxicities such as myelosuppression and gastrointestinal distress (PubMed, PMID: 30256151).

Other names

DNA replication machineryReplisomeDNA synthesis apparatusDNA replication complex

The primary mechanisms include the competitive inhibition of DNA polymerases, the incorporation of fraudulent nucleotides into the growing DNA strand causing chain termination, and the depletion of the cellular pool of deoxyribonucleotide triphosphates (dNTPs) through the inhibition of enzymes like ribonucleotide reductase.